SEARCH RESULT

Tuesday, October 1, 2019
Boehringer Ingelheim obtains European authorisation for porcine parvovirus vaccine
No Abstract
Monday, September 23, 2019
Boehringer Ingelheim breaks ground for vaccine production center in France
Boehringer Ingelheim is developing one of the largest biotechnology production sites for veterinary vaccines in Europe, building on France's pioneering expertise in veterinary public health (VPH).
Tuesday, August 13, 2019
Boehringer Ingelheim opens animal health facility in China
No Abstract
Tuesday, May 28, 2019
Boehringer Ingelheim and Harbin Veterinary Research Institute set up 'industry-academia-research' exchange platform
Boehringer Ingelheim and Harbin Veterinary Research Institute (HVRI), subordinated to the Chinese Academy of Agricultural Sciences (CAAS), jointly unveiled the first 'industry-academia-research' exchange platform set up by an agricultural r ...
Tuesday, April 2, 2019
Boehringer Ingelheim and Dopharma complete acquisition of French brand and production site
Following a pre-signed agreement in October 2018, Boehringer Ingelheim and Dopharma have announced the effective acquisition of the Saint-Herblon (France, Loire-Atlantique) production site and the Coophavet brand by Dopharma.
Tuesday, February 26, 2019
Boehringer Ingelheim and GNA Biosolutions partner on rapid ASF diagnostics development
Boehringer Ingelheim and GNA Biosolutions have entered into a research collaboration focused on the development of a rapid African swine fever (ASF) diagnostic test.
Thursday, January 24, 2019
Boehringer Ingelheim launches its first veterinary vaccines produced in China
Boehringer Ingelheim has announced that swine vaccine Ingelvac® PRRS MLV, produced by its veterinary vaccine manufacturing plant in the China Medical City in Taizhou, Jiangsu Province, is now officially supplied to the China market.
Tuesday, January 15, 2019
Boehringer Ingelheim launches tool to aid in prevention of African swine fever
No Abstract
Wednesday, May 31, 2017
Boehringer Ingelheim launches first Mycoplasma synoviae vaccine in Korea
Boehringer Ingelheim (BI) Korea has launched the first Mycoplasma synoviae vaccine in Korea, Vaxsafe MS, in Daejeon on May 11, 2017.
Wednesday, May 31, 2017
Boehringer Ingelheim holds first Avian Academy with Cargill
From May 9-12, 2017, the first Avian Academy was conducted in Bangkok in cooperation with Cargill Asia Poultry Group.
Wednesday, May 31, 2017
Boehringer Ingelheim Malaysia holds business forum with key poultry producer
On May 3, 2017, the Boehringer Ingelheim (BI) Business Forum was conducted with the theme "Growth of online retailing for food products" in Malaysia.
Tuesday, April 11, 2017
Boehringer Ingelheim, Novozymes to collaborate in probiotics for poultry hatcheries
Boehringer Ingelheim Animal Health and Novozymes had announced in late March, a strategic collaboration to develop and commercialise probiotics for global poultry production.
Tuesday, April 11, 2017
Boehringer Ingelheim aims to be new world leader in animal health
Three months after acquiring animal health leader Merial in a strategic transaction with Sanofi, Boehringer Ingelheim revealed its ambition to compete for industry leadership worldwide in animal health.
Friday, March 31, 2017
Novozymes: Collaboration with Boehringer Ingelheim on probiotics for poultry
Boehringer Ingelheim Animal Health and Novozymes have announced a strategic collaboration to develop and commercialise probiotics for global poultry production.
Friday, July 15, 2016
Sanofi to transfer Merial to Boehringer Ingelheim's hands
Sanofi and Boehringer Ingelheim has announced in late June the signing of contracts to secure a strategic transaction initiated in December 2015.

Follow Us

FacebookTwitterLinkedIn